相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?
Wai-Tong Ng et al.
JAMA ONCOLOGY (2022)
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy A Phase 3 Randomized Clinical Trial
Guo-Ying Liu et al.
JAMA ONCOLOGY (2022)
Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?
Wai-Tong Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma-Is This the New Standard of Care?
Maurice Willis
JAMA ONCOLOGY (2022)
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
Xiao-Yun Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
Pierre Blanchard et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen et al.
LANCET (2021)
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Hai-Qiang Mai et al.
NATURE MEDICINE (2021)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Anthony T. C. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis
Federico Rotolo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis
Federico Rotolo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen et al.
EUROPEAN JOURNAL OF CANCER (2017)
Nasopharyngeal carcinoma incidence and mortality in China, 2013
Kuang-Rong Wei et al.
CHINESE JOURNAL OF CANCER (2017)
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang et al.
LANCET (2016)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
A new prognostic histopathologic classification of nasopharyngeal carcinoma
Hai-Yun Wang et al.
CHINESE JOURNAL OF CANCER (2016)
Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
Yu-Pei Chen et al.
BMC CANCER (2015)
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
Antonio Gnoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: A prospective study with long-term follow-up
WeiWei Xiao et al.
ORAL ONCOLOGY (2015)
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
Chih-Wen Twu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
Mariana S. Nars et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients
Xueming Sun et al.
RADIATION ONCOLOGY (2013)
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen et al.
LANCET ONCOLOGY (2012)
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Herbert H. Loong et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Local Control, Survival, and Late Toxicities of Locally Advanced Nasopharyngeal Carcinoma Treated by Simultaneous Modulated Accelerated Radiotherapy Combined With Cisplatin Concurrent Chemotherapy Long-Term Results of a Phase 2 Study
Wei-Wei Xiao et al.
CANCER (2011)
Different Clinical Significance of Pre- and Post-treatment Plasma Epstein-Barr Virus DNA Load in Nasopharyngeal Carcinoma Treated with Radiotherapy
Xue Hou et al.
CLINICAL ONCOLOGY (2011)
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials
Anne W. M. Lee et al.
EUROPEAN JOURNAL OF CANCER (2011)
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
Sheng-Fa Su et al.
Chinese Journal of Cancer (2011)
Pattern of failure and prognostic factors for primary nasopharyngeal carcinoma (NPC) treated with intensity modulated radiotherapy (IMRT)
C. Zhao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer
Daniel Chua et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
AWM Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
J Wee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Another way to estimate outcome of advanced nasopharyngeal carcinoma - Is concurrent chemoradiotherapy adequate?
JC Lin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
DTT Chua et al.
ORAL ONCOLOGY (2003)
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men
YC Chien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
